focus -WSS

focus

author：explore 2025-09-29 20:53:20 - browse：53619

Illustration of a doctor and patient. The shadow behind the doctor displays 0s and 1s for artificial intelligence. –– health tech coverage from STAT — Molly Ferguson for STAT

The world’s largest technology companies are racing to build generative AI into every corner of health and medicine.

Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients. Not to be outdone, Amazon has unveiled a service to help build clinical note scribes, and is separately working to embed generative AI in drug research and development.

All of this has unfolded faster than federal regulators could blink — or answer questions about how the technology should be tested and evaluated, whether it will help or hurt patients, and how it will impact privacy and the use of personal data.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Pushing for an NIH office for post

WSS

Why scientists need input from humanists on sensitive research

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Medicare coverage of Wegovy, once blocked, now looks possible

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Boston's new lab space is opening empty

hotspot

focus

focus

Medical leaders decry Supreme Court decision on affirmative action

President Biden's budget: Here's what you might have missed

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

FDA approval of Sarepta Duchenne genetic therapy gives me hope

HHS secretary Becerra pressed on Change HealthCare cyberattack

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Cholera vaccine supplies dangerously low, outbreaks surging

Guidelines to prevent youth baseball injuries need more muscle

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

hotspot

NEJM study measures Covid brain fog, impact on IQ

Neuroscience renaissance leads to new crop of psychiatric drugs

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Children’s Hospital revives plan for pedestrian bridge

5 ways to address the shortage of health care workers

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Wikipedia

focus

focus

entertainment